Literature DB >> 32554590

Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.

Nicholas C Wu1, Andrew J Thompson2, Juhye M Lee3,4,5, Wen Su6, Britni M Arlian2, Jia Xie7, Richard A Lerner7,8, Hui-Ling Yen6, Jesse D Bloom3,4,9, Ian A Wilson10,8.   

Abstract

The discovery and characterization of broadly neutralizing human antibodies (bnAbs) to the highly conserved stem region of influenza hemagglutinin (HA) have contributed to considerations of a universal influenza vaccine. However, the potential for resistance to stem bnAbs also needs to be more thoroughly evaluated. Using deep mutational scanning, with a focus on epitope residues, we found that the genetic barrier to resistance to stem bnAbs is low for the H3 subtype but substantially higher for the H1 subtype owing to structural differences in the HA stem. Several strong resistance mutations in H3 can be observed in naturally circulating strains and do not reduce in vitro viral fitness and in vivo pathogenicity. This study highlights a potential challenge for development of a truly universal influenza vaccine.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32554590      PMCID: PMC7412937          DOI: 10.1126/science.aaz5143

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  45 in total

1.  A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen.

Authors:  Antonietta Impagliazzo; Fin Milder; Harmjan Kuipers; Michelle V Wagner; Xueyong Zhu; Ryan M B Hoffman; Ruud van Meersbergen; Jeroen Huizingh; Patrick Wanningen; Johan Verspuij; Martijn de Man; Zhaoqing Ding; Adrian Apetri; Başak Kükrer; Eveline Sneekes-Vriese; Danuta Tomkiewicz; Nick S Laursen; Peter S Lee; Anna Zakrzewska; Liesbeth Dekking; Jeroen Tolboom; Lisanne Tettero; Sander van Meerten; Wenli Yu; Wouter Koudstaal; Jaap Goudsmit; Andrew B Ward; Wim Meijberg; Ian A Wilson; Katarina Radošević
Journal:  Science       Date:  2015-08-24       Impact factor: 47.728

2.  A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

Authors:  Y Okuno; Y Isegawa; F Sasao; S Ueda
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

3.  Massively parallel de novo protein design for targeted therapeutics.

Authors:  Aaron Chevalier; Daniel-Adriano Silva; Gabriel J Rocklin; Derrick R Hicks; Renan Vergara; Patience Murapa; Steffen M Bernard; Lu Zhang; Kwok-Ho Lam; Guorui Yao; Christopher D Bahl; Shin-Ichiro Miyashita; Inna Goreshnik; James T Fuller; Merika T Koday; Cody M Jenkins; Tom Colvin; Lauren Carter; Alan Bohn; Cassie M Bryan; D Alejandro Fernández-Velasco; Lance Stewart; Min Dong; Xuhui Huang; Rongsheng Jin; Ian A Wilson; Deborah H Fuller; David Baker
Journal:  Nature       Date:  2017-09-27       Impact factor: 49.962

4.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

5.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

6.  Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.

Authors:  M Gordon Joyce; Adam K Wheatley; Paul V Thomas; Gwo-Yu Chuang; Cinque Soto; Robert T Bailer; Aliaksandr Druz; Ivelin S Georgiev; Rebecca A Gillespie; Masaru Kanekiyo; Wing-Pui Kong; Kwanyee Leung; Sandeep N Narpala; Madhu S Prabhakaran; Eun Sung Yang; Baoshan Zhang; Yi Zhang; Mangaiarkarasi Asokan; Jeffrey C Boyington; Tatsiana Bylund; Sam Darko; Christopher R Lees; Amy Ransier; Chen-Hsiang Shen; Lingshu Wang; James R Whittle; Xueling Wu; Hadi M Yassine; Celia Santos; Yumiko Matsuoka; Yaroslav Tsybovsky; Ulrich Baxa; James C Mullikin; Kanta Subbarao; Daniel C Douek; Barney S Graham; Richard A Koup; Julie E Ledgerwood; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola; Adrian B McDermott
Journal:  Cell       Date:  2016-07-21       Impact factor: 41.582

7.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

8.  Complete mapping of viral escape from neutralizing antibodies.

Authors:  Michael B Doud; Scott E Hensley; Jesse D Bloom
Journal:  PLoS Pathog       Date:  2017-03-13       Impact factor: 6.823

9.  Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Authors:  Jianhua Sui; William C Hwang; Sandra Perez; Ge Wei; Daniel Aird; Li-mei Chen; Eugenio Santelli; Boguslaw Stec; Greg Cadwell; Maryam Ali; Hongquan Wan; Akikazu Murakami; Anuradha Yammanuru; Thomas Han; Nancy J Cox; Laurie A Bankston; Ruben O Donis; Robert C Liddington; Wayne A Marasco
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

10.  The influenza virus hemagglutinin head evolves faster than the stalk domain.

Authors:  Ericka Kirkpatrick; Xueting Qiu; Patrick C Wilson; Justin Bahl; Florian Krammer
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

View more
  14 in total

1.  A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination.

Authors:  Julie E Raab; Jason Gorman; Rebecca A Gillespie; Crystal S F Cheung; Reda Rawi; Sarah F Andrews; Lauren Y Cominsky; Jeffrey C Boyington; Adrian Creanga; Chen-Hsiang Shen; Darcy R Harris; Adam S Olia; Alexandra F Nazzari; Tongqing Zhou; Katherine V Houser; Grace L Chen; John R Mascola; Barney S Graham; Masaru Kanekiyo; Julie E Ledgerwood; Peter D Kwong; Adrian B McDermott
Journal:  Nat Med       Date:  2022-02-03       Impact factor: 53.440

2.  Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Katharine H D Crawford; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; David Veesler; Jesse D Bloom
Journal:  bioRxiv       Date:  2020-06-17

3.  Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Daniel Ellis; Katharine H D Crawford; Adam S Dingens; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Neil P King; David Veesler; Jesse D Bloom
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

4.  Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination.

Authors:  Julianna Han; Aaron J Schmitz; Sara T Richey; Ya-Nan Dai; Hannah L Turner; Bassem M Mohammed; Daved H Fremont; Ali H Ellebedy; Andrew B Ward
Journal:  Cell Rep       Date:  2021-01-26       Impact factor: 9.423

Review 5.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

6.  Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.

Authors:  Hanjun Zhao; Xinjie Meng; Zheng Peng; Hoiyan Lam; Chuyuan Zhang; Xinxin Zhou; Jasper Fuk-Woo Chan; Richard Yi Tsun Kao; Kelvin Kai-Wang To; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

Review 7.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

Review 8.  Structural Biology of Influenza Hemagglutinin: An Amaranthine Adventure.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Viruses       Date:  2020-09-22       Impact factor: 5.048

9.  Identification and Characterization of Swine Influenza Virus H1N1 Variants Generated in Vaccinated and Nonvaccinated, Challenged Pigs.

Authors:  Álvaro López-Valiñas; Marta Sisteré-Oró; Sergi López-Serrano; Laura Baioni; Ayub Darji; Chiara Chiapponi; Joaquim Segalés; Llilianne Ganges; José I Núñez
Journal:  Viruses       Date:  2021-10-16       Impact factor: 5.048

10.  Broadly neutralizing antibodies target a haemagglutinin anchor epitope.

Authors:  Jenna J Guthmiller; Julianna Han; Henry A Utset; Lei Li; Linda Yu-Ling Lan; Carole Henry; Christopher T Stamper; Meagan McMahon; George O'Dell; Monica L Fernández-Quintero; Alec W Freyn; Fatima Amanat; Olivia Stovicek; Lauren Gentles; Sara T Richey; Alba Torrents de la Peña; Victoria Rosado; Haley L Dugan; Nai-Ying Zheng; Micah E Tepora; Dalia J Bitar; Siriruk Changrob; Shirin Strohmeier; Min Huang; Adolfo García-Sastre; Klaus R Liedl; Jesse D Bloom; Raffael Nachbagauer; Peter Palese; Florian Krammer; Lynda Coughlan; Andrew B Ward; Patrick C Wilson
Journal:  Nature       Date:  2021-12-23       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.